Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Sleep problems and behavioural interventions

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Sleep-associated respiratory, neurological or safety emergency

Cyanosis, prolonged apnoea, severe respiratory effort, an unresponsive event, status epilepticus, overdose or imminent self-harm is not a routine sleep problem.

Action: Use ABCDE, open the airway, give oxygen and ventilation support as required, check capillary glucose and call emergency paediatric help. Treat a prolonged convulsive seizure according to the local status pathway. A child who is blue, difficult to rouse, injured or breathing abnormally after a nocturnal event needs urgent assessment even if the event has stopped. Suspected sedative or melatonin overdose requires exact product and amount, observations and National Poisons Information Service or TOXBASE-guided care. Escalate suicidal intent, unsafe nighttime wandering or caregiver exhaustion that prevents safe supervision through urgent mental-health, safeguarding and family-support pathways.

Synopsis

Assess paediatric sleep in developmental and family context, distinguish behavioural insomnia and normal parasomnias from respiratory, neurological and mental-health disease, implement collaborative behavioural treatment, and reserve medicine for selected specialist indications with safe monitoring.

  • First-line assessment is a sleep history plus a 2-week diary recording sleep opportunity, estimated sleep, awakenings, naps, events, caffeine, screens and daytime effects.
  • Set one consistent wake time every day, provide age-appropriate sleep opportunity, use morning light and daytime activity, and build a predictable calm wind-down.
  • For behavioural insomnia, first-line management is a collaboratively chosen routine plus behavioural strategy such as bedtime fading, graduated checking or consistent low-interaction return to bed.
  • Bedtime fading starts near the time the child actually falls asleep, then advances earlier in 5–15-minute steps once sleep onset is reliably quick.
  • Typical night terrors occur from deep sleep in the first part of the night with autonomic distress, poor responsiveness and no next-day memory; protect from injury and do not force awakening.
  • Polysomnography is the reference-standard test for suspected obstructive sleep apnoea, but referral and local prioritisation depend on clinical severity and service pathway.
  • Melatonin is not first-line for ordinary bedtime resistance. Consider it only after behavioural and environmental work when a specialist indication and product-specific plan are clear.

Key red flags

Cyanosis, prolonged breathing pauses, marked chest recession, stridor or difficult arousal during sleep requires urgent respiratory assessment.

Habitual loud snoring with witnessed apnoeas, gasping, restless sleep, morning headache, growth concern or daytime behavioural change suggests obstructive sleep apnoea.

Stereotyped events, tonic posturing, rhythmic jerking, incontinence, lateral tongue injury, prolonged confusion or events many times nightly raises nocturnal epilepsy.

Cataplexy, irresistible daytime sleep attacks, sleep paralysis or hypnagogic hallucinations requires specialist evaluation for narcolepsy.

Painful urge to move the legs at rest, relief with movement and evening predominance suggests restless legs; assess iron risk and mimics.

Frequent dangerous sleepwalking, leaving the home, injury, safeguarding concern or family collapse requires an immediate safety plan and specialist support.

Night terrors beginning after age 5, or continuing beyond age 12, should prompt neurological assessment under NICE guidance rather than automatic reassurance.

Investigation priorities

01
First-line: 2-week sleep diaryFirst stepFirst line

Quantify schedule, opportunity, latency, waking, naps, events, triggers and daytime function before and during intervention.

02
Reference standard: polysomnography for obstructive sleep apnoeaReference standard

Measure sleep state, airflow, respiratory effort, gas exchange, heart rhythm and movements when sleep-disordered breathing is suspected.

Management branches

AssessmentClassify before intervening

Sleep timing, night events or daytime function concerns the family.

  1. Screen for respiratory compromise, seizure, acute mental-health risk, overdose, regression and safeguarding or supervision danger.
  2. Take an age-appropriate sleep, health, medicine and environmental history and start a 2-week diary with wake time, naps and events.
  3. Classify behavioural, circadian, respiratory, movement, parasomnia or neurological pattern and investigate only what the clinical question requires.

Key medicines

Melatonin prolonged-release tablets, SlenytoLicensed paediatric indications: start 2 mg once daily, 30–60 minutes before bedtime and with or after food. If response is inadequate, increase to 5 mg and then maximum 10 mg daily according to the SmPC and specialist review.Swallow whole; do not crush or substitute another release profile. Review somnolence, headache, mood or behavioural change and seizure control. Check hepatic or renal disease, pregnancy potential in adolescents, CYP1A2 interactions including fluvoxamine, and smoking exposure. Evaluate after at least 3 months and stop if no clinically relevant effect; review at least every 6 months.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG127 suspected neurological conditions in childrenUK referral recommendations for night terrors, sleepwalking, narcolepsy features and neurological red flags.
  • NHS sleep and young childrenParent-facing UK advice on routines, settling and common night waking.
  • Slenyto prolonged-release melatonin SmPCLicensed paediatric indications, exact dose escalation, administration, interactions and review requirements.
  • NICE NG87 attention deficit hyperactivity disorderUK sleep monitoring and specialist medication context for children with ADHD.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom